Evaluating Serum Heat Shock Protein Levels as Novel Biomarkers for Atrial Fibrillation

Denise M S van Marion1, Eva A H Lanters2, Kennedy S Ramos1,2

  • 1Department of Physiology, Amsterdam Cardiovascular Sciences, Amsterdam UMC, Vrije University, 1081HV Amsterdam, The Netherlands.

Cells
|September 19, 2020
PubMed

Insights

Heat shock proteins (HSP) do not stage atrial fibrillation (AF) or predict recurrence. However, elevated HSP27 levels after pulmonary vein isolation (PVI) may indicate future AF recurrence in patients.

Area of Science:

  • Cardiology
  • Biomarkers
  • Electrophysiology

Background:

  • Atrial fibrillation (AF) staging is crucial for understanding disease progression and treatment outcomes.
  • Blood-based heat shock protein (HSP) levels are investigated as potential biomarkers for AF staging and predicting recurrence.
  • Identifying patients at higher risk for AF recurrence post-treatment is essential.

Purpose of the Study:

  • To evaluate the relationship between serum HSP levels and the presence/stage of AF.
  • To assess the correlation between serum HSP levels and AF recurrence after electrocardioversion (ECV) or pulmonary vein isolation (PVI).
  • To determine if HSP levels can predict AF recurrence post-ablation.

Main Methods:

  • Serum samples were collected from 297 participants (98 controls, 199 AF patients) undergoing ECV or PVI.
  • Levels of HSP27, HSP70, cardiovascular (cv)HSP, and HSP60 were measured pre-intervention and at 3, 6, and 12 months post-PVI.
  • Statistical analyses were performed to compare HSP levels across AF stages and correlate them with recurrence.

Main Results:

  • No significant differences in baseline HSP levels were found between control and AF patients across different stages (PAF, PeAF, LSPeAF).
  • Baseline HSP levels did not correlate with AF recurrence following ECV or PVI.
  • In patients experiencing AF recurrence post-PVI, HSP27 levels were significantly elevated compared to baseline, unlike in non-recurrent cases.

Conclusions:

  • Baseline serum HSP levels do not appear to be associated with AF presence, stage, or recurrence risk.
  • Elevated HSP27 levels post-PVI may serve as a predictive marker for AF recurrence within one year of ablative therapy.
  • Further research into HSP27's role in post-ablation AF recurrence is warranted.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
399
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
644
Dysrhythmias V: Evaluating Dysrhythmias01:30

Dysrhythmias V: Evaluating Dysrhythmias

Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...
230
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
288
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
119